Columnist Caroline Gainer is no longer haunted by a weight gain that was crucial in helping her adapt to her COPD and to her ...
While COPD imposes some limitations, columnist Caroline Gainer has learned that choosing to rest can be a radical act of self ...
November marks COPD Awareness Month, and advocates this year will focus on action, and education about chronic obstructive ...
Fluticasone (brand name Flovent) is a prescription corticosteroid used to prevent breathing difficulties, chest tightness, wheezing and coughing caused by respiratory disorders such as COPD. It works ...
COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...
Trelegy Ellipta is a once-daily, single inhaler triple therapy from GSK, in collaboration with Innoviva, approved as a long-term maintenance treatment for certain patients with chronic obstructive ...
There is no need to do any special preparation for this test. However, if you are on oxygen therapy, oxygen values must be constant for 20 minutes before the test. If you are taking medication to make ...
Note: This is the second article in a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. The first part can be ...
Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...
While it’s important to check with your doctor before beginning any new exercise regimen, most patients with COPD benefit greatly from regular exercise for a number of reasons. Exercise won’t cure you ...
DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results